PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJEFI.L Regulatory News (JEFI)

  • There is currently no data for JEFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company Update

10 Jan 2022 07:00

RNS Number : 8476X
Jupiter Emerging & Frontier Inc.Tst
10 January 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

 

Jupiter Emerging & Frontier Income Trust PLC (the "Company" or "JEFI")

 

Legal Entity Identifier: 213800RLXLM87NO26S30

 

Company Update

 

The Board of the Company announces that it intends to convene a general meeting of the Company (the "General Meeting"). The Board has carried out a shareholder consultation regarding the Company's redemption facility, through which shareholders are entitled to request the redemption of all or part of their holding of ordinary shares of 1 penny each ("Ordinary Shares") (the "Redemption Facility") on an annual basis. Taking into account the views of shareholders, the Board is proposing the Redemption Facility will be amended so that it is offered every three years, next to occur in June 2024; and that the maximum number of redemption requests that may be accepted at each redemption event will in aggregate be 20% of the Company's outstanding ordinary share capital. Operation of the Redemption Facility will continue to be at the discretion of the Board. Alongside the proposed changes to the Redemption Facility, the Board intends to implement a continuation vote every three years. Operation of the Redemption Facility will be conditional on shareholders approving the Company's continuation vote at the preceding annual general meeting of the Company.

 

The above changes require amendments to be made to the Company's articles of association (the "Articles"), which requires the approval of shareholders at the General Meeting. Alongside the proposed changes to the Articles to be considered at the General Meeting, the Board intends to put a resolution to shareholders in connection with the continuation of the Company. It is the Board's intention to recommend that shareholders vote in favour of the changes to the Articles and in favour of continuation of the Company. It is expected that the circular and notice of general meeting will be sent to shareholders in February 2022.

 

John Scott, Chairman of JEFI commented: "When the Covid-19 pandemic struck in 2020, the markets into which JEFI invests were particularly badly affected, being quick to fall and slower than the developed markets to recover. Having traded at, or close to, a premium for most of the time since our IPO in 2017, JEFI's shares have subsequently traded at a significant discount, presenting the opportunity for investors to buy in at a discount, in the knowledge that they can redeem at close to the prevailing net asset value per share every June. The experience of 2021, when some 30% of JEFI's shares were redeemed, served to demonstrate that the Redemption Facility as currently offered is incompatible with the long term viability of the Company.

 

"Taking into account the views of shareholders, the Board believes that the interests of the Company and of shareholders as a whole will be better served by amending the Redemption Facility in a manner which will limit the scale of future outflows, while at the same time offering shareholders a range of protections, including a triennial redemption programme and continuation vote. We retain our confidence in Ross Teverson and his team and take great encouragement from the recovery both in JEFI's net asset value and in the earnings from our investments."

 

Ross Teverson, Fund Manager of JEFI commented: "The Company's portfolio holdings have proven their resilience through what has been an unprecedented and challenging period for many emerging and frontier market businesses. Income generation has already recovered to above pre-Covid levels and we believe that a combination of attractive portfolio valuations and continued earnings growth should be conducive to a positive outlook for total returns in 2022."

 

 

Enquiries:

 

Magnus Spence / Nick Black

Jupiter Asset Management Limited, Company Secretary

020 3817 1000

investmentcompanies@jupiteram.com

 

Media contact:

Powerscourt

020 7250 1446

jupiter@powerscourt-group.com 

 

 

10 January 2022 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFLVLLIAIIF
Date   Source Headline
18th Feb 202210:06 amRNSNet Asset Value(s)
17th Feb 20229:58 amRNSNet Asset Value(s)
16th Feb 20225:31 pmRNSPortfolio Update
16th Feb 20224:39 pmRNSHolding(s) in Company
16th Feb 202210:29 amRNSNet Asset Value(s)
15th Feb 202210:34 amRNSNet Asset Value(s)
14th Feb 202210:26 amRNSNet Asset Value(s)
11th Feb 202212:34 pmRNSGM Statement
11th Feb 202211:06 amRNSNet Asset Value(s)
10th Feb 202210:33 amRNSNet Asset Value(s)
9th Feb 202212:54 pmRNSNet Asset Value(s)
8th Feb 20229:55 amRNSNet Asset Value(s)
7th Feb 202210:56 amRNSNet Asset Value(s)
4th Feb 20225:32 pmRNSDirector/PDMR Shareholding
4th Feb 202211:30 amRNSNet Asset Value(s)
3rd Feb 20224:54 pmRNSFund Manager Share Purchase
3rd Feb 202210:33 amRNSNet Asset Value(s)
2nd Feb 202211:10 amRNSNet Asset Value(s)
1st Feb 20223:25 pmRNSDirector/PDMR Shareholding
1st Feb 20221:53 pmRNSDirector/PDMR Shareholding
1st Feb 20221:31 pmRNSDirector/PDMR Shareholding
1st Feb 202211:04 amRNSNet Asset Value(s)
31st Jan 20226:21 pmRNSTotal Voting Rights
31st Jan 202210:24 amRNSNet Asset Value(s)
28th Jan 202211:50 amRNSAnnual Financial Report
28th Jan 202211:07 amRNSNet Asset Value(s)
27th Jan 202210:50 amRNSNet Asset Value(s)
26th Jan 202210:44 amRNSNet Asset Value(s)
25th Jan 202210:42 amRNSNet Asset Value(s)
24th Jan 202211:05 amRNSNet Asset Value(s)
21st Jan 202211:26 amRNSNet Asset Value(s)
20th Jan 20229:47 amRNSNet Asset Value(s)
19th Jan 20229:33 amRNSNet Asset Value(s)
18th Jan 20224:31 pmRNSPortfolio Update
18th Jan 202210:15 amRNSNet Asset Value(s)
17th Jan 202211:20 amRNSNet Asset Value(s)
14th Jan 202210:06 amRNSNet Asset Value(s)
13th Jan 202210:37 amRNSNet Asset Value(s)
12th Jan 20225:29 pmRNSDirector/PDMR Shareholding
12th Jan 20229:52 amRNSNet Asset Value(s)
11th Jan 202210:28 amRNSNet Asset Value(s)
10th Jan 202210:29 amRNSNet Asset Value(s)
10th Jan 20227:00 amRNSCompany Update
7th Jan 202210:19 amRNSNet Asset Value(s)
6th Jan 202210:29 amRNSNet Asset Value(s)
5th Jan 202210:01 amRNSNet Asset Value(s)
4th Jan 202210:11 amRNSNet Asset Value(s)
31st Dec 202112:53 pmRNSTotal Voting Rights
31st Dec 202110:31 amRNSNet Asset Value(s)
30th Dec 202111:27 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.